Anthem Blue Cross Blue Shield of California policy

Selected Protein Biomarker Algorithmic Assays

Selected Protein Biomarker Algorithmic Assays is a public Anthem Blue Cross Blue Shield of California policy (policy LAB.00011). It lists 9 CPT or HCPCS codes, 5 of them on the Anthem Blue Cross Blue Shield of California prior authorization list. Not a coverage decision; the payer's own document governs.

View the original policy ↗

Check eligibility for free

No account required. Sign a BAA to see plan details, coordination of benefits and more

Payer
Anthem Blue Cross Blue Shield of California
Policy number
LAB.00011
Line of business
Commercial
Source
www.anthem.com

Codes in this policy

The CPT and HCPCS codes the policy names. A policy can name a code it excludes. Prior authorization status is from the Anthem Blue Cross Blue Shield of California prior authorization list.

CodePrior authorizationDescription on the prior authorization listOther Anthem Blue Cross Blue Shield of California policies
0080UOn the listOncology (lung), mass spectrometric analysis of galectin-3- binding protein and scavenger receptor cysteine-rich type 1 protein M130, with five clinical risk factors (age, smoking status, nodule diameter, nodule-spiculation status and nodule location), utilizing plasma, algorithm reported as a categorical probability of malignancyPolicies naming 0080U
0092UNot listedPolicies naming 0092U
0174UNot listedPolicies naming 0174U
0247UOn the listObstetrics (preterm birth), insulin-like growth factor-binding protein 4 (IBP4), sex hormone-binding globulin (SHBG), quantitative measurement by LC-MS/MS, utilizing maternal blood and blood derivatives, combined with clinical data, reported as predictive-risk stratification for spontaneous preterm birthPolicies naming 0247U
0249UNot listedPolicies naming 0249U
0342UNot listedPolicies naming 0342U
0360UOn the listOncology (lung), enzyme-linked immunosorbent assay (ELISA) of 7 autoantibodies (p53, NY-ESO-1, CAGE, GBU4- 5, SOX2, MAGE A4, and HuD), plasma, algorithm reported as a categorical result for risk of malignancyPolicies naming 0360U
81538On the listOncology (lung), mass spectrometric 8-protein signature, including amyloid A, utilizing serum, prognostic and predictive algorithm reported as good versus poor overall survivalPolicies naming 81538
81599On the listUnlisted multianalyte assay with algorithmic analysisPolicies naming 81599

All Anthem Blue Cross Blue Shield of California policies · Anthem Blue Cross Blue Shield of California prior authorization CPT list

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.